FindTrial
Sign In

Developing and Testing an Art-Based Programme for Individuals with Schizophrenia

Developing and Piloting an Art-Based Intervention for Individuals with Schizophrenia: An Intervention Mapping Approach - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098624
Enrollment
40
Registered
2025-12-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G- Mental Health

Interventions

Intervention1: Art Based Intervention: A two-phase study: (1) A structured art-based psychosocial rehabilitation programme will be co-designed using Intervention Mapping. Selected activities (mandala
detailed components will be determined based on co-design outcomes. (2) pilot testing of the finalized intervention with individuals with schizophrenia. The time frame of the intervention phase is 6 w

Sponsors

Schizophrenia Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: For Mental Health Professionals: -Willing to participant -Have a minimum 2 years of experience working with persons with severe mental illness For Caregivers: - Willing to participate - Caregivers of persons with schizophrenia For Patients: -Clinical diagnosis of schizophrenia (ICD-10 F20) confirmed by a psychiatrist. -Clinically stable on pharmacological treatment for at least 3 months. -Able to understand simple instructions and provide informed consent. -Willing to participate in group sessions.

Exclusion criteria

Exclusion criteria: For Mental Health Professionals: - Any condition that may limit participation in group activities. For Caregivers: - Any condition that may limit participation in group activities. For Patients: -Acute psychotic exacerbation at the time of recruitment. -Severe cognitive impairment or intellectual disability interfering with participation. -Comorbid substance use disorder. -Any medical/neurological condition that may limit participation in group activities.

Design outcomes

Primary

MeasureTime frame
Scale for the Assessment of Negative Symptoms (SANS)Timepoint: Baseline and after 6 weeks—

Secondary

MeasureTime frame
The Social Occupational Functioning Scale (SOFS)Timepoint: Baseline & after 6 weeks;Mindful Attention Awareness Scale (MAAS)Timepoint: Baseline & after 6 weeks—

Countries

India

Contacts

Public ContactSai Rasikaa R N

Schizophrenia Research Foundation (India)

subhashini@scarfindia.in9841474668

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026